Publication: Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: An analysis of 53 cases
Abstract
Herein, we aimed to describe the outcomes of patients with blood stream infections due to carbapenem-resistant Klebsiella pneumoniae (CR-Kp) who received ertapenem plus meropenem combination treatment (EMCT). A total of 53 patients with culture proven CR-Kp bacteremia treated with ertapenem + meropenem were included. The patients with secondary bacteremia due to urinary tract infection exhibited a significantly lower 1-month mortality (OMM), particularly in those with microbiological eradication and those with end-of-treatment success. Salvage EMCT resulted in 49% 1-month survival.
Description
Keywords
Therapy, Infections, Double carbapenem therapy, Carbapenem-resistant klebsiella pneumonia, Bacteremia, Science & technology, Life sciences & biomedicine, Infectious diseases, Microbiology, Infectious diseases, Microbiology
Citation
Collections
Metrikler